tiprankstipranks
BriaCell Achieves Breakthrough in Breast Cancer Treatment
Company Announcements

BriaCell Achieves Breakthrough in Breast Cancer Treatment

Story Highlights

BriaCell Therapeutics (TSE:BCT) has released an update.

Don't Miss our Black Friday Offers:

BriaCell Therapeutics reports a breakthrough in treating a breast cancer patient with severe brain metastasis, achieving complete resolution of the tumor in the brain after 8 and 11 months of treatment. The patient, who had not responded to 8 previous treatments, showed significant tumor reduction with BriaCell’s Bria-IMT™ regimen and continues to make progress.

For further insights into TSE:BCT stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskBriaCell Highlights Promising Breast Cancer Trial Results
TheFlyBriaCell to highlight OS, clinical benefit data of Bria-IMT in MBC patients
TheFlyBriaCell director Marc Lustig resigns
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App